ArticleActa pharmaceutica Sinica. B2022

Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer.

Chao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.